Inhibition of expression of the chromatin remodeling inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death

Molecular Cancer Research

Volumn 7, Issue 12, 2009, Pages 1984-1999

  Ye, Yin ^a,b   Xiao, Yi ^c   Wang, Wenting ^c   Wang, Qien ^c   Yearsley, Kurtis ^c   Wani, Altaf A ^c   Yan, Qintao ^c   Gao, Jian Xin ^c   Shetuni, Brandon S ^c   Barsky, Sanford H ^a,b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b NEVADA CANCER INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ATR PROTEIN; BRCA1 PROTEIN; CASPASE 9; CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE H2AX; PROTEIN 14 3 3; PROTEIN P21; PROTEIN P53; PROTEIN SWI; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNF;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA DAMAGE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SNF2H GENE; SNF2L GENE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; CLUSTER ANALYSIS; DNA DAMAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASMS; PHOSPHORYLATION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 73849085416     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0119     Document Type: Article

References (48)

1. Eisen JA, Sweder KS, Hanawalt PC. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 1995;23:2715-23.
2. Chai J, Charboneau AL, Betz BL, Weissman BE. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 2005;65:10192-8.
3. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004;4:133-42.
4. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-9.
5. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187-91.
6. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999;13:1924-35.
7. Harikrishnan KN, Chow MZ, Baker EK, et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 2005;37:254-64.
8. Li H, Ilin S, Wang W, et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006;442:91-5.
9. Wysocka J, Swigut T, Xiao H, et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006;442:86-90.
10. Downs JA, Allard S, Jobin-Robitaille O, et al. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol Cell 2004;16:979-90.
11. van Attikum H, Fritsch O, Hohn B, Gasser SM. Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair. Cell 2004;119:777-88.
12. Morrison AJ, Highland J, Krogan NJ, et al. INO80 and γ-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. Cell 2004;119:767-75.
13. Morrison AJ, Shen X. DNA repair in the context of chromatin. Cell Cycle 2005;4:568-71.
14. Morrison AJ, Shen X. Chromatin modifications in DNA repair. Cell Differ 2006;41:109-25.
15. Morrison AJ, Kim JA, Person MD, et al. Mec1/Tel1 Phosphorylation of the INO80 chromatin remodeling complex influences DNA damage checkpoint responses. Cell 2007;130:499-511.
16. Wong LY, Recht J, Laurent BC. Chromatin remodeling and repair of DNA double-strand breaks. J Mol Histol 2006;37:261-9.
17. Osley MA, Tsukuda T, Nickoloff JA. ATP-dependent chromatin remodeling factors and DNA damage repair. Mutat Res 2007;618:65-80.
18. Elfring LK, Daniel C, Papoulas O. Genetic analysis of brahma: the Drosophila homolog of the yeast chromatin remodeling factor SWI2. Genetics 1998;148:251-65.
19. Okabe I, Bailey LC, Attree O, et al. Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res 1992;20:4649-55.
20. Aihara T, Miyoshi Y, Koyama K, et al. Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI. Cytogenet Cell Genet 1998;81:191-3.
21. Tsukiyama T, Palmer J, Landel CC, Shiloach J, Wu C. Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae. Genes Dev 1999;13:686-97.
22. Eberharter A, Vetter I, Ferreira R, Becker PB. ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD-histone contacts. EMBO J 2004;23:4029-39.
23. Tsukiyama T, Wu C. ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell 1995;83:1011-20.
24. Tsukiyama T, Daniel C, Tamkun J, Wu C. Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell 1995;83:1021-6.
25. Ito T, Bulger M, Pazin MJ, Kobayashi R, Kadonaga JT. ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell 1997;90:145-55.
26. Varga-Weisz PD, Wilm M, Bonte E, et al. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 1997;388:598-602.
27. Bouazoune K, Brehm A. ATP-dependent chromatin remodeling complexes in Drosophila. Chromosome Res 2006;14:433-49.
28. Xi RW, Xie T. Stem cell self-renewal controlled by chromatin remodeling factors. Science 2005;310:1487-9.
29. Barak O, Lazzaro MA, Cooch NS, Picketts DJ, Shiekhattar R. A tissuespecific, naturally occurring human SNF2L variant inactivates chromatin remodeling. J Biol Chem 2004;279:45130-8.
30. Lubs HA, Chiurazzi P, Arena JF, Schwartz C, Tranebjaerg L, Neri G. XLMR genes: update 1996. Am J Med Genet 1996;64:147-57.
31. Bao Y, Shen X. SnapShot: chromatin remodeling complexes. Cell 2007;129:632.
32. Banting GS, Barak O, Ames TM, et al. CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L. Hum Mol Genet 2005;14:513-24.
33. Lazzaro MA, Pepin D, Pescador N, Murphy BD, Vanderhyden BC, Picketts DJ. The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells. Mol Endocrinol 2006;20:2406-17.
34. Pepin D, Vanderhyden BC, Picketts DJ, Murphy BD. ISWI chromatin remodeling in ovarian somatic and germ cells: revenge of the NURFs. Trends Endocrinol Metab 2007;18:215-24.
35. Mohamed MA, Greif PA, Diamond J, et al. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007;99:908-15.
36. Lazzaro MA, Picketts DJ. Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l. J Neurochem 2001;77:1145-56.
37. Kastan MB, Lim DS. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 2000;1:179-86.
38. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
39. Shimada M, Nakanishi M. DNA damage checkpoints and cancer. J Mol Hist 2006;37:253-60.
40. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
41. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999;401:616-20.
42. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999;59:5079-84.
43. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed Ecadherin/α, β-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001;61:5231-41.
44. Donehower LA, Godley LA, Aldaz CM. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 1995;9:882-95.
45. Damalas A, Ben-Ze'ev A, Simcha I. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999;18:3054-63.
46. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling. Trends Mol Med 2007;13:373-80.
47. Sternlicht M, Safarians S, Calcaterra TC, Barsky SH. Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma. In Vitro Cell Dev Biol 1996;32:550-63.
48. Sternlicht M, Safarians S, Rivera SP, Barsky SH. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 1996;74:781-96.